CD44 and cancer: Putative copy number alterations analyzed by GISTIC (Genomic Identification of Significant Targets in Cancer) through cBioPortal indicate that the increase in copy number of the CD44 gene could not explain the observed mRNA upregulation (Figure 2B, left panel).